Neuropsychological Evaluation Of Somatoform And Other Functional Somatic Conditions

Neuropsychologists are provided with little formal education and training regarding the identification and measurement of somatoform symptoms, yet these conditions are highly prevalent, with estimates indicating that 20% of general medical patients and 30% of neurologic clinic patients present with symptoms lacking medical explanation. This book provides neuropsychologists with comprehensive information and specific practice recommendations for the assessment of patients with somatoform conditions. The first four chapters discuss the genesis of somatoform and other functional somatic symptom disorders, and the next seven chapters address somatoform conditions in the context of nonepileptic seizures, multiple chemical sensitivity and other claimed toxic exposures, pseudotremor and other nonphysiologic movement disorders, postconcussion syndrome, chronic pain/fibromyalgia/complex regional pain syndrome, attention deficit disorder, and auto-immune disease. Chapters are also included that address the use of the MMPI-2-RF in differentiating somatoform disorder and malingering, medically unexplained symptoms in non-English-speaking individuals; workplace factors in somatization; and testimony involving somatoform conditions. The book is targeted for practicing neuropsychologists, clinical psychologists including those specializing in behavioral medicine, and students in training.

Understanding Somatization in the Practice of Clinical Neuropsychology is written for neuropsychologists who wish to improve their ability to diagnose and treat, or recommend treatment for, patients with somatoform disorders. It blends evidence-based recommendations with sound practical advice for working with these challenging patients. A Continuing Education (CE) component administered by the American Academy of Clinical Neuropsychology is included, as is access to the author's workshop presentation materials.

This collection of essays forms a comprehensive overview of this crucial component of human cognitive function.

With the aging of the baby boomers and medical advances that promote longevity, older adults are rapidly becoming the fastest growing segment of the population. As the population ages, so does the incidence of age related disorders. Many predict that 15% - 20% of the baby-boomer generation will develop some form of cognitive decline over the course of their lifetime, with estimates escalating to up to 50% in those achieving advanced age. Although much attention has been directed at Alzheimer’s disease, the most common form of dementia, it is estimated that nearly one third of those cases of cognitive decline result from other neuropathological mechanisms. In fact, many patients diagnosed with Alzheimer’s disease likely have co-morbid disorders that can also influence cognition (i.e., vascular cognitive impairment), suggesting mixed dementias are grossly under diagnosed. The Clinical Handbook on the Neuropsychology of Aging and Dementia is a unique work that provides clinicians with expert guidance and a hands-on approach to neuropsychological practice with older adults. The book will be divided into two sections, the first addressing special considerations for the evaluation of older adults, and the second half focusing on common referral questions likely to be encountered when working with this age group. The authors of the chapters are experts and are recognized by their peers as opinion leaders in their chosen chapter topics. The field of neuropsychology has played a critical role in developing methods for early identification of late life cognitive disorders as well as the differential diagnosis of dementia. Neuropsychological assessment provides valuable clinical information regarding the nature and severity of cognitive symptoms associated with dementia. Each chapter will reinforce the notion that neuropsychological measures provide the clinician with sensitive tools to differentiate normal age-related cognitive decline from disease-associated impairment, aid in differential diagnosis of cognitive dysfunction in older adults, as well as identify cognitive deficits most likely to translate into functional impairments in everyday life.

Print+CourseSmart

Neuropsychological assessment is a difficult and complicated process. Often, experienced clinicians as well as trainees and students gloss over fundamental problems or fail to consider potential sources of error. Since formal test data on the surface appear unambiguous and objective, they may fall into the habit of overemphasizing tests and their scores and underemphasizing all the factors that affect the validity, reliability, and interpretability of test data. But interpretation is far from straightforward, and a pragmatic application of assessment results requires attention to a multitude of issues. This long-awaited, updated, and greatly expanded second edition of the Clinician's Guide to Neuropsychological Assessment, like the first, focuses on the clinical practice of neuropsychology. Orienting readers to the entire multitude of issues, it guides them step by step through evaluation and helps them avoid common misconceptions, mistakes, and methodological pitfalls. It is divided into three sections: fundamental elements of the assessment process; special issues, settings, and populations; and new approaches and methodologies. The authors, all of whom are actively engaged in the clinical practice of neuropsychological assessment, as well as in teaching and research, do an outstanding job of integrating the academic and the practical. The Clinician's Guide to Neuropsychological Assessment, Second Edition will be welcomed as a text for graduate courses but also as an invaluable hands-on handbook for interns, postdoctoral fellows, and experienced neuropsychologists alike. No other book offers its combination of breadth across batteries and approaches, depth, and practicality.

The go-to resource for clinical and forensic practice has now been significantly revised with 85% new material, reflecting the tremendous growth of the field. Leading authorities synthesize the state of the science on symptom feigning in cognitive testing and present evidence-based recommendations for distinguishing between credible and noncredible performance. A wide range of performance validity tests (PVTs) and symptom validity tests (SVTs) are critically reviewed and guidelines provided for applying them across differing cognitive domains and medical, neurological, and psychiatric conditions. The book also covers validity testing in forensic settings and with particular populations, such as ethnic and linguistic minority group members. New to This Edition *Numerous new authors, a greatly expanded range of topics, and the latest data throughout. *"Clinical primer" chapter on how to select and interpret appropriate PVTs. *Chapters on methods for validity testing in visual–spatial, processing speed, and language domains and with cognitive screening instruments and personality inventories. *Chapter on methods for interpreting multiple PVTs in combination. *Chapters on additional populations (military personnel, children and adolescents) and clinical problems (dementia, somatoform/conversion disorder). *Chapters on research methods for validating PVTs, base rates of feigned mild traumatic brain injury, and more.

During the twentieth century, new neurobehavioral diseases appeared or were described for the first time. Exposure to certain toxins or noxious environments, for example, produced illnesses that did not exist before the twentieth century. In addition, established illnesses were reconceptualized with regard to their cause or neurobiological basis. Autism, for instance, was described for the first time during the twentieth century and may not have existed previously. Its cause was subsequently reconceptualized from a disorder related to inadequate parenting, to a brain disorder with possible genetic causes. These major new and reconceptualized disorders are reviewed in this book with regard to their neurocognitive characteristics, causes, and outcome. Disorders covered include ADHD in adults, Lewy Body Dementia, autism, multiple chemical sensitivity, deployment syndromes found in veterans of the Persian Gulf and Afghanistan wars, effects of low birth weight, neurobehavioral respiratory disorders, PTSD, and comorbid disorders such as depression and brain injury. The expert reviews of these disorders give balanced coverage of the ongoing and often controversial research findings that continue to generate much professional and public interest. This volume provides an essential resource for researchers, instructors, and clinicians in the fields of neuropsychology, psychiatry, behavioral neurology, neuroscience, toxicology, as well as the informed general public concerned and affected by these disorders.